Weight-loss drugs can improve kidney health, study finds
GLP-1 receptor agonists significantly lower the risk of kidney failure, worsening kidney function, and death due to kidney disease by approximately 19%.
NK2R control of energy expenditure and feeding to treat metabolic diseases - Nature
GLP-1 receptor agonists offer effective treatment for obesity and T2D, but their impact is reduced in individuals with both conditions.
Weight-loss drugs can improve kidney health, study finds
GLP-1 receptor agonists significantly lower the risk of kidney failure, worsening kidney function, and death due to kidney disease by approximately 19%.
NK2R control of energy expenditure and feeding to treat metabolic diseases - Nature
GLP-1 receptor agonists offer effective treatment for obesity and T2D, but their impact is reduced in individuals with both conditions.
A Drug Half as Good as Ozempic for One-30th the Price
New obesity drugs like GLP-1 receptor agonists are in the spotlight, but older medications also offer weight loss benefits.
There is a lack of awareness about older obesity drugs that have been effective for years prior to the introduction of newer medications like Ozempic and Wegovy.
Women advised to pair effective contraception with skinny jabs'
Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.
I've been practicing medicine at a renowned institution for 40 years. Society isn't ready for us to reverse the aging process across an entire population
The surge in GLP-1 receptor agonists signals a transformative moment in weight loss treatments, with potential links to future advancements in aging research.
Should young bariatric surgery patients use weight-loss drugs? - Harvard Gazette
The use of GLP-1 receptor agonists in adolescents warrants closer examination due to limited research and safety concerns compared to their use in adults.
Skeletal muscle health amid growing use of weight loss medications
The importance of maintaining muscle mass during medically induced weight loss is crucial, especially with the use of GLP-1 receptor agonists.
All About Ozempic and the Next Generation of Obesity Drugs
Ozempic belongs to a class of GLP-1 receptor agonists, aiding weight loss and diabetes treatment with similar drugs like Wegovy, Mounjaro, and Zepbound.
A Drug Half as Good as Ozempic for One-30th the Price
New obesity drugs like GLP-1 receptor agonists are in the spotlight, but older medications also offer weight loss benefits.
There is a lack of awareness about older obesity drugs that have been effective for years prior to the introduction of newer medications like Ozempic and Wegovy.
Women advised to pair effective contraception with skinny jabs'
Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.
I've been practicing medicine at a renowned institution for 40 years. Society isn't ready for us to reverse the aging process across an entire population
The surge in GLP-1 receptor agonists signals a transformative moment in weight loss treatments, with potential links to future advancements in aging research.
Should young bariatric surgery patients use weight-loss drugs? - Harvard Gazette
The use of GLP-1 receptor agonists in adolescents warrants closer examination due to limited research and safety concerns compared to their use in adults.
Skeletal muscle health amid growing use of weight loss medications
The importance of maintaining muscle mass during medically induced weight loss is crucial, especially with the use of GLP-1 receptor agonists.
All About Ozempic and the Next Generation of Obesity Drugs
Ozempic belongs to a class of GLP-1 receptor agonists, aiding weight loss and diabetes treatment with similar drugs like Wegovy, Mounjaro, and Zepbound.
Opinion | Why We May Soon Use Ozempic to Treat Addiction
GLP-1 receptor agonists may help treat addiction-related issues such as obesity and substance use disorders, demonstrating positive effects on cravings and overdose risks.
Diabetes drugs test a new side effect: slowing down symptoms of Parkinson's
GLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively.
Opinion | Why We May Soon Use Ozempic to Treat Addiction
GLP-1 receptor agonists may help treat addiction-related issues such as obesity and substance use disorders, demonstrating positive effects on cravings and overdose risks.
Diabetes drugs test a new side effect: slowing down symptoms of Parkinson's
GLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively.
Opinion | Inflammation May Be the Root of Our Maladies
The emerging understanding of GLP-1 receptor agonists indicates their benefits extend beyond weight loss and diabetes to include reducing inflammation and improving overall health.
Does Medicare cover Wegovy? Insurance provider could start covering certain weight loss drugs
Medicare may cover Wegovy for certain beneficiaries with heart disease.
CMS guidance allows using FDA-approved medications for specific uses under Part D plans.
Oprah Exits Weight Watchers Board After Admitting She Took Weight Loss Meds
Oprah Winfrey is leaving Weight Watchers after almost a decade, donating her stake to a museum.
Her departure comes after admitting to considering weight loss medications like Ozempic or Wegovy.